Drugs / Boostrix TM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00610168 | Jan → Apr 2008 | diphtheria, tetanus | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Boostrix TM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00610168 ↗ |
| Modality | Vaccine | “Single booster dose of vaccine” NCT00610168 ↗ |
| Route | Intramuscular | “administered as an intramuscular injection” NCT00610168 ↗ |